Boehringer Ingelheim Limited

Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com
Patient Information Leaflet last updated on the eMC: 24/07/2009
PIL Aptivus 250mg Soft Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/07/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
  • Changes to therapeutic indications
Updated on 07/05/2009 and displayed until 24/07/2009
Reasons for adding or updating:
  • Change to drug interactions
Updated on 20/08/2008 and displayed until 07/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Improved Electronic Presentation
  • Change to Further Information section
  • Change of contra-indications
  • Change to drug interactions
  • Improved Electronic Presentation
  • Change to Further Information section
  • Change to date of revision
Updated on 28/11/2007 and displayed until 20/08/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/06/2007 and displayed until 28/11/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 21/03/2007 and displayed until 08/06/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 09/08/2006 and displayed until 21/03/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/05/2006 and displayed until 09/08/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   tipranavir


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk